Skip to main content

Table 2 Predictive factors for ESRD by univariate and multivariate logistic regression

From: Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study

  Univariate Logistic Multivariate Logistic
OR (95%CI) P OR (95%CI) P
Mesangial hypercellularity
 M0 1   1  
 M1 9.12 (4.10–20.27) <0.001 5.10 (1.33–19.60) 0.018
Endocapillary hypercellularity
 E0 1   1  
 E1 1.21 (0.57–2.55) 0.617 1.62 (0.33–8.02) 0.557
Segmental Glomerulosclerosis
 S0 1   1  
 S1 3.43 (1.61–7.32) 0.001 0.57 (0.12–2.74) 0.480
Tubular atrophy/interstitial fibrosis
 T0 1   1  
 T1 12.71 (5.25–30.76) <0.001 1.82 (0.33–10.0) 0.492
 T2 14.33 (3.43–59.91) <0.001 0.32 (0.02–5.48) 0.431
At the time of biopsy
 eGFR 0.96 (0.94–0.97) <0.001 0.97 (0.93–0.998) 0.039
 Gender (male) 1.83 (0.89–3.78) 0.100 5.38 (0.82–35.49) 0.081
 Age 1.0 (0.97–1.04) 0.830 0.92 (0.83–1.01) 0.087
 UA 1.74 (1.39–2.16) <0.001 0.94 (0.59–1.50) 0.795
 Hb 0.82 (0.68–0.99) 0.039 1.14 (0.60–2.17) 0.692
 Alb 0.40 (0.24–0.67) 0.001 0.53 (0.18–1.62) 0.267
 TC 1.01 (1.0–1.02) 0.006 1.003 (0.99–1.02) 0.687
 24 h urine protein 1.60 (1.30–1.96) <0.001 1.17 (0.86–1.58) 0.313
 Hypertension (yes) 1.84 (0.92–3.68) 0.085 4.33 (0.79–23.80) 0.092
 Macro-hematuria (yes) 0.19 (0.04–0.85) 0.030 0.05 (0–9.02) 0.264
Follow-up
 TA-UA 2.36 (1.74–3.19) <0.001 2.06 (1.09–3.90) 0.026
 TA-Hb 0.61 (0.48–0.76) <0.001 0.53 (0.30–0.91) 0.029
 TA-Alb 0.18 (0.08–0.38) <0.001 0.48 (0.10–2.37) 0.367
 TA-TC 1.01 (1.0–1.02) 0.002 1.004 (0.99–1.02) 0.697
  1. OR odds ratio, 95% CI 95% confidence interval